The Antitrust Week In Review
Posted 06/1/15
Here are some of the developments in antitrust news this past week that we found interesting and are following.
Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion. The Federal Trade Commission has announced that its seven-year lawsuit against Cephalon, now owned by Teva Pharmaceutical Industries, would be settled for $1.2 billion, the largest amount ever secured by the competition watchdog. The...